Observational studyAsian Pacific journal of cancer prevention : APJCP2022

Improvement in the Neutrophil-Lymphocyte Ratio after Combined Fluorouracil, Leucovorina and Oxaliplatino based (FOLFOX) Chemotherapy for Stage III Colon Cancer is Associated with Improved Minimal Residual Disease and Outcome.

Nigel P Murray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.